Pfizer’s CEO replaced
December 6, 2010
Pfizer’s CEO, Jeffrey Kindler, was abruptly replaced over the weekend. Many analyst believe that it was related to the poor stock performance, unsuccessful drug development, and bad acquisitions. In January of 2009, Mr. Kindler acquired Wyeth. The HCC was very critical of the move. The Fox Business discussion can be viewed below.
Op-Ed, WSJ.com coverage | apples49 | 
December 6, 2010 5:48 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
